The surge in research and development activities focused on personalized medicine coincides with the rapidly decreasing cost of human genome mapping and a greater understanding of disease heterogeneity. As a researcher, you struggle with high attrition rate based on lack of clinical efficacy. It is crucial to your studies to utilize ethically collected, well-characterized human specimens and comprehensive tissue-based research services.
Look to BioIVT for expertise in the processes required for the ethical acquisition of biospecimens that cover a wide range of disease states and the protocols needed for the production of reliable data.
Unparalleled access to over 200 IRB-approved collection sites
Access to a comprehensive array of biospecimens across multiple sample types and disease indications
Standardization and quality control coupled with the ability to customize collections to meet your specific criteria and research needs
Covering disease areas including oncology, immunology, neurology, cardiovascular, infectious disease, and pediatric/prenatal, our quality, customization, expertise and reliability allow us to partner with you to accelerate your research.
Design based on the patient’s genetic makeup or particular disease phenotype, personalized therapeutics or diagnostic tools mean significantly higher efficacy.
Global tissue supply chain with extensive inventory of tissue product sets per indication
Ethical and regulatory traceability for each case
Expanded offering through the acquisition of Asterand Bioscience
Available as both banked inventory or custom collection with associated clinical data such as medication, cancer or disease stage, clinical lab values such as cholesterol and liver function, RF value and viral serology.
Customized collections kits:
Donor specifications, protocols, collection containers and more
Repeat donor collections for longitudinal studies
Access to unique or rare patient populations, including pediatric and pregnant donors
Matched sets from individual donors
Primary Cells and Cell Lines
We offer primary isolated cells from oncology and other diseased populations, useful in assay development and the identification of diagnostic and prognostic markers. In addition, our cell lines have the fidelity of primary cells.
Complete clinical data included with all samples
Customizable PBMC collections for specific inclusion criteria
Additional characterization available, including HLA typing
Screening & Genotyping
The incorporation of genetic analysis into the development of therapeutic agents and diagnostic tools relies on access to large collections of biospecimens with a specific genetic phenotype. Whether you need an effective approach for determining the status of various somatic mutations, hotspot variants, copy number variations or fusions in human tissue samples or a ready-banked inventory of pre-screened specimens, we have your solution.
To address this, we are able to combine immediate access to large collections of human biospecimens with expertise in the design and execution of: